DAP.F Danaher Corporation
Healthcare · Diagnostics & Research
211.40
-0.52%
About the company
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
52-week range
Dividend deep dive
DANAHER CORP., operating in the Healthcare sector within Diagnostics & Research, currently provides a dividend yield of 0.81%. According to Yield Theory, the current yield suggests the company is undervalued relative to its 5-year average yield of 0.44% and 5-year high of 0.62%. On intrinsic lenses, its price momentum is scored at 4.0 and its value at 5.0 (on a 0-10 scale). The company holds an overall rating score of 6.0.
Dividend history
Danaher Corp. has a dividend streak of 1 year. The company has demonstrated strong dividend growth, with a 3-year compound annual growth rate (CAGR) of 8.58% and a 5-year CAGR of 12.20%. At this 5-year growth rate, the dividend is projected to double in approximately 5.9 years. The Chowder Number is 13.0, surpassing the 12.0 threshold. Annual dividend payments in EUR have increased from 0.3496 in 2014 to 0.9438 in 2023 and 2024, with a projected 1.1186 for 2025.
Dividend safety
The dividend for Danaher Corp. is rated as 'safe'. The company's payout ratio stands at 28.78% based on EPS, indicating strong coverage for its dividend payments.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 14 Sep 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Ex-dividend date The cut-off day: you must already own the stock before it to receive the next dividend. Buy on or after, and the seller keeps that payment. Learn more →
The cash usually arrives later, sometimes a month or more after.
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
Held by 1 investor
Appears in these lists
DAP.F qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track DAP.F and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →